EUCTR2013-003552-21-RO进行中（未招募）1 期
Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients with Type 2 Diabetes.
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 420
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men or women aged 18 to 80 years with T2DM. Eligibility criteria include: HbA1c =7.0% and =10.5% at screening and treated with diet and exercise alone or on a stable dose of metformin (=1000 mg/day) for 3 months prior to screening. BMI =23 and =45 kg/m2 at screening.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 337
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 38
排除标准
- •Patients are excluded from participation if they; are women of child bearing potential; used thiazolidinediones within 3 months prior to screening, or any other drugs for treatment of hyperglycemia (except metformin) within the prior 2 months; have used insulin for diabetic control for more than 6 consecutive days within the prior year; and if they have impaired renal function (serum creatinine >124 µmol/L [1.4 mg/dL] in women, >133 µmol/L [1.5 mg/dL] in men).
研究者
相似试验
进行中（未招募）
1 期
A study to compare a new drug for Type 2 Diabetes to placebo (a placebo looks like the study drug but has no medicine) and to a treatment already available for Type 2 Diabetes.Diabetes Mellitus, Type 2EUCTR2013-003552-21-GREli Lilly and Company375
进行中（未招募）
不适用
A study to compare a new drug for Type 2 Diabetes to placebo (a placebo looks like the study drug but has no medicine) and to a treatment already available for Type 2 Diabetes.Diabetes Mellitus, Type 2EUCTR2013-003552-21-PLEli Lilly and Company540
已完成
2 期
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 DiabetesDiabetes Mellitus, Type 2NCT02119819OPKO Health, Inc.420
尚未招募
不适用
OXYTOCIN VERSUS OXYTOCIN AND MELATONIN IN THE REDUCTION OF BLOOD LOSS AT CAESAREAN SECTION AT THE ALEX EKWUEME FEDERAL UNIVERSITY HOSPITAL, ABAKALIKIPregnancy and ChildbirthPACTR202201838645377Dr Nwaedu Uchenna254
进行中（未招募）
3 期
Comparison of the efficacy of oxtyocin agonist to oxytocin in the prevention of postpartum hemorrhage (PPH) in women undergoing vaginal deliveryvaginal deliveryvaginal delivery and blood lossReproductive Health and Childbirth - Childbirth and postnatal carePostpartum HemorrhageACTRN12608000396325Dr Farouk720